Bretton Fund: UnitedHealth Group Incorporated (UNH) had a Quarter from Hell

Core Insights - Bretton Fund's second quarter 2025 performance was 2.70%, underperforming the S&P 500 Index which returned 10.94% [1] - The fund's underperformance was attributed to a focus on fundamentals rather than market sentiment, particularly in light of the president's easing of tariff threats [1] - Notable underperformers included Berkshire Hathaway and AutoZone, which were categorized as "safe stocks" rather than due to operational issues [1] Company Highlights: UnitedHealth Group Incorporated (NYSE:UNH) - UnitedHealth Group's stock experienced a significant decline of 39.88% over the past 52 weeks, despite a one-month return of 14.31% [2] - As of September 25, 2025, UnitedHealth Group's stock closed at $345.56, with a market capitalization of $312.965 billion [2] - The fund reported that UnitedHealth Group's stock drop contributed to a 2.0% loss for the fund this quarter, indicating a substantial impact on overall performance [3] Financial Performance - UnitedHealth Group reported revenues of nearly $112 billion for the second quarter of 2025, reflecting a 13% increase compared to the same quarter the previous year [4] - The company ranked 18th among the 30 Most Popular Stocks Among Hedge Funds, with 159 hedge fund portfolios holding its stock at the end of the second quarter, up from 139 in the previous quarter [4] Investment Perspective - While UnitedHealth Group is recognized for its potential as an investment, the analysis suggests that certain AI stocks may offer greater upside potential with less downside risk [4]